RSV antibodies for RIVM

Auto-translated from Dutch

Original title: RSV-Antistoffen tbv het RIVM

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Published: Oct 14, 2026

Updated: Oct 14, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals, Vaccines and Laboratory. Located in Netherlands, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Dutch

This tender from the Netherlands concerns the acquisition of Respiratory Syncytial Virus (RSV) antibodies for the National Institute for Public Health and the Environment (RIVM), as part of the National Vaccination Program. The contracting authority is seeking to procure these specific biological materials, which are likely intended for research, diagnostic, or potentially therapeutic purposes within the public health framework. Typical requirements for such a tender include the supply of high-quality, well-characterized antibodies with documented purity, specificity, and efficacy. Bidders must demonstrate compliance with relevant pharmaceutical and laboratory standards, potentially including Good Manufacturing Practice (GMP) or Good Laboratory Practice (GLP). The tender may specify the required quantity, storage conditions, delivery timelines, and regulatory compliance documentation. Experience in supplying biological reagents to national health institutes or research organizations is often preferred. The RIVM will likely require detailed technical data sheets, certificates of analysis, and proof of reliable supply chain management to ensure the integrity and availability of these critical RSV antibodies.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 14, 2026. Last refreshed 1 day ago. Original language: Dutch. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) has issued 99 procurement notices on BidsFactory, including 21 currently open and 38 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Research & Innovation. All notices are published for Netherlands. Notices are distributed via Netherlands TenderNed and TED - Tenders Electronic Daily (EU). Most recent publication: October 15, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Rijksinstituut voor Volksgezondheid en Milieu (RIVM) in Netherlands. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Netherlands. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.